<H1>Chapter DOI: 10.1208/aapsj070354<br/>Cited-By Count: 46</H1><table border="1" width="30%"><tr><td>Total References</td><td>126</td></tr><tr><td>Springer references</td><td>17</td></tr><tr><td>Non Springer references</td><td>109</td></tr><tr><td>BibStructured Count</td><td width="10%">122</td></tr><tr><td>BibUnstructured Count</td><td width="10%">4</td></tr><tr><td>DOI already available in SpringerLink</td><td>71</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>17</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>17</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>18</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>10</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Hammarlund-Udenaes M, Paalzow LN, de Lange EC. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1997;14:128&#8211;134.</td><td><a href=http://dx.doi.org/10.1023/A:1012080106490>10.1023/A:1012080106490</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>De Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.<Emphasis Type="Italic">Clin Pharmacokinet</Emphasis>. 2002;41:691&#8211;703.</td><td><a href=http://dx.doi.org/10.2165/00003088-200241100-00001>10.2165/00003088-200241100-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Van der Graaf PH, Danhof M. Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.<Emphasis Type="Italic">Int J Clin Pharmacol Ther</Emphasis>. 1997;35:442&#8211;446.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Garrido M, Gubbens-Stibbe J, Tukker E, et al. Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor &#8220;knockdown&#8221; in vivo.<Emphasis Type="Italic">Pharm Res</Emphasis> 2000;17:653&#8211;659.</td><td><a href=http://dx.doi.org/10.1023/A:1007513812018>10.1023/A:1007513812018</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Cleton A, Odman J, Van der Graaf PH, Ghijsen W, Voskuyl R, Danhof M. Mechanism-based modeling of functional adaptation upon chronic treatment with midazolam.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:321&#8211;327.</td><td><a href=http://dx.doi.org/10.1023/A:1007505223519>10.1023/A:1007505223519</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Cox EH, Kerbusch T, Van der Graaf PH, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat. Correlation with binding at the &#956;-opioid receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1998;284:1095&#8211;1103.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Collins JM, Dedrick LD. Distributed model for drug delivery to CSF and brain tissue.<Emphasis Type="Italic">J Am Physiol</Emphasis>. 1983;14:R303-R310.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Wang YF, Welty DF. The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1996;13:398&#8211;403.</td><td><a href=http://dx.doi.org/10.1023/A:1016092525901>10.1023/A:1016092525901</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Bodor N, Brewster ME. Problems of delivery of drugs to the brain.<Emphasis Type="Italic">Pharmacol Ther</Emphasis>. 1982;19:337&#8211;386.</td><td><a href=http://dx.doi.org/10.1016/0163-7258(82)90073-0>10.1016/0163-7258(82)90073-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Begley DJ. ABC transporters and the blood-brain barrier.<Emphasis Type="Italic">Curr Pharm Des</Emphasis>. 2004;10:1295&#8211;1312.</td><td><a href=http://dx.doi.org/10.2174/1381612043384844>10.2174/1381612043384844</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Tamai I, Yamashita J, Kido Y, et al. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2000;295:146&#8211;152.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Cordon-Cardo C, O&#8217;Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 1989;86:695&#8211;689.</td><td><a href=http://dx.doi.org/10.1073/pnas.86.2.695>10.1073/pnas.86.2.695</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1987;84:7735&#8211;7738.</td><td><a href=http://dx.doi.org/10.1073/pnas.84.21.7735>10.1073/pnas.84.21.7735</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>de Boer AG, van der Sandt I, Glillard PJ. The role of drug transporters at the blood-brain barrier.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol</Emphasis>. 2003;43:629&#8211;656.</td><td><a href=http://dx.doi.org/10.1146/annurev.pharmtox.43.100901.140204>10.1146/annurev.pharmtox.43.100901.140204</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Zhang Y, Schuetz JD, Elmquist WF, Miller DW. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;311:449&#8211;455.</td><td><a href=http://dx.doi.org/10.1124/jpet.104.068528>10.1124/jpet.104.068528</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Park S, Sinko PJ. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2005;312:1249&#8211;1256.</td><td><a href=http://dx.doi.org/10.1124/jpet.104.076216>10.1124/jpet.104.076216</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Abbott NJ, Revest PA. Control of brain endothelial permeability.<Emphasis Type="Italic">Cerebrovasc Brain Metab Rev</Emphasis>. 1991;3:39&#8211;72.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Cornford EM, Young D, Paxton JW, Sofia RD. Blood-brain barrier penetration of felbamate.<Emphasis Type="Italic">Epilepsia</Emphasis>. 1992;33:944&#8211;954.</td><td><a href=http://dx.doi.org/10.1111/j.1528-1157.1992.tb02205.x>10.1111/j.1528-1157.1992.tb02205.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibChapter</td><td>Johansson BB. Hypertension. In: Pardridge WM, ed.<Emphasis Type="Italic">Introduction to the Blood-brain Barrier: Methodology, Biology, and Pathology</Emphasis>. Cambridge, UK: Cambridge University Press; 1998:427&#8211;433.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1017/CBO9780511570216>10.1017/CBO9780511570216</a></td><td><b>CrossRef-Meta</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Hesselink MB, Smolders H, Eilbacher B, De Boer AG, Boer AG, Breimer DD, Danysz W. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: Microdialysis and maximum electroshock seizures studies.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1999;290:543&#8211;550.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Malhotra BK, Lemaire M, Sawchuk RJ. Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely moving rats utilizing microdialysis.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1994;11:1223&#8211;1231.</td><td><a href=http://dx.doi.org/10.1023/A:1018921906993>10.1023/A:1018921906993</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Ooie T, Terasaki T, Suzuki H, Sugiyama Y. Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1997;283:293&#8211;304.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR23</td><td>BibArticle</td><td>de Lange ECM, de Vries JD, Zurcher C, Danhof M, de Boer AG, Breimer DD. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1995;12:1924&#8211;1931.</td><td><a href=http://dx.doi.org/10.1023/A:1016239822287>10.1023/A:1016239822287</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>de Lange ECM, Danhof M, de Boer AG, Breimer DD. Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain.<Emphasis Type="Italic">Brain Res</Emphasis>. 1994;666:1&#8211;8.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(94)90276-3>10.1016/0006-8993(94)90276-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>de Lange ECM, Bouw MR, Danhof M, de Boer AG, Breimer DD. Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1995;116:2538&#8211;2544.</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1995.tb15107.x>10.1111/j.1476-5381.1995.tb15107.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, VolumeID, ArticleTitle, FirstPage, Year</td><td>CrossRef</td></tr><tr><td>CR26</td><td>BibArticle</td><td>de Lange EC, de Bock G, Schinkel AH, de Boer AG, Breimer DD. BBB transport and P-glycoprotein functionality using MDR1A(&#8211;/&#8211;) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1998;15:1657&#8211;1665.</td><td><a href=http://dx.doi.org/10.1023/A:1011988024295>10.1023/A:1011988024295</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Xie R, Hammarlund-Udenaes M, de Boer AG, de Lange EC. The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdrla(&#8211;/&#8211;) and mdrla(+/+) mice.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1999;128:563&#8211;568.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0702804>10.1038/sj.bjp.0702804</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>de Lange ECM, Marchand S, van den Berg D, et al. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.<Emphasis Type="Italic">Eur J Pharmacol Sci</Emphasis>. 2000;12:85&#8211;93.</td><td><a href=http://dx.doi.org/10.1016/S0928-0987(00)00149-4>10.1016/S0928-0987(00)00149-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>de Lange ECM, Danhof M, de Boer AG, Breimer DD. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.<Emphasis Type="Italic">Brain Res Brain Res Rev</Emphasis>. 1997;25:27&#8211;49.</td><td><a href=http://dx.doi.org/10.1016/S0165-0173(97)00014-3>10.1016/S0165-0173(97)00014-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Breimer DD, Danhof M. Prediction of the time course of drug effects in vivo in health and disease (intensity and duration).<Emphasis Type="Italic">Clin Pharmacokinet</Emphasis>. 1997;32:259&#8211;267.</td><td><a href=http://dx.doi.org/10.2165/00003088-199732040-00001>10.2165/00003088-199732040-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Breimer DD, Danhof M. Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The &#8216;wooden shoe&#8217; paradigm.<Emphasis Type="Italic">Clin Pharmacokinet</Emphasis>. 1997;32:259&#8211;267.</td><td><a href=http://dx.doi.org/10.2165/00003088-199732040-00001>10.2165/00003088-199732040-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Cleton A, Odman J, van der Graaf PH, Ghijsen W, Voskuyl R, Danhof M. Mechanism-based modeling of functional adaptation upon chronic treatment with midazolam.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:321&#8211;327.</td><td><a href=http://dx.doi.org/10.1023/A:1007505223519>10.1023/A:1007505223519</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Danhof M, Mandema JW, Hoogerkamp A, Math&#244;t RAA. Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives.<Emphasis Type="Italic">Eur J Drug Metab Pharmacokinet</Emphasis>. 1993;18:41&#8211;47.</td><td><a href=http://dx.doi.org/10.1007/BF03220007>10.1007/BF03220007</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2, Year, FirstPage</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Black JW, Leff P. Operational models of pharmacological agonism.<Emphasis Type="Italic">Proc R Soc Lond B Biol Sci</Emphasis>. 1983;220:141&#8211;162.</td><td><a href=http://dx.doi.org/10.1098/rspb.1983.0093>10.1098/rspb.1983.0093</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, VolumeID, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Black JW, Leff P, Shankley NP, Wood J. An operational model of pharmacological agonism: the effect of E/[A], curve shape on agonist dissociation constant estimation.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1985;84:561&#8211;571.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1985.tb12941.x>10.1111/j.1476-5381.1985.tb12941.x</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID</td><td>CrossRef</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Van der Graaf PH, Van Schaick EA, Visser SA, De Greef HJ, Ijzerman AP, Danhof M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1999;290:702&#8211;709.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Furchgott RF. The use of &#946;-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes.<Emphasis Type="Italic">Adv Drug Res</Emphasis>. 1966;3:21&#8211;55.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Christ GJ. Determination of agonist dissociation constants in isolated vasculature: equivalence of estimates obtained by the method of partial irreversible receptor inactivation and a novel application of the operational model of pharmacological agonism.<Emphasis Type="Italic">Life Sci</Emphasis>. 1990;47:1867&#8211;1874.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(90)90290-8>10.1016/0024-3205(90)90290-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Welty DF, Schielke GP, Vartanian MG, Taylor CP. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate.<Emphasis Type="Italic">Epilepsy Res</Emphasis>. 1993;16:175&#8211;181.</td><td><a href=http://dx.doi.org/10.1016/0920-1211(93)90078-L>10.1016/0920-1211(93)90078-L</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibChapter</td><td>Danhof M, Mandema JW. Modeling of relationships between pharmacokinetics and pharmacodynamics. In: Welling PG, Tse F, eds.<Emphasis Type="Italic">Pharmacokinetics</Emphasis>. New York: Marcel Dekker, 1994;139&#8211;174.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Dubey RK, McAllister CB, Inoue M, Wilkinson GR. Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1989;84:1155&#8211;1159.</td><td><a href=http://dx.doi.org/10.1172/JCI114279>10.1172/JCI114279</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Robinson PJ, Rapoport SI. Kinetics of protein binding determine rates of uptake of drugs by brain.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1986;251:R1212-R1220.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Rowley M, Kulagowski JJ, Watt AP, et al. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1997;40:4053&#8211;4068.</td><td><a href=http://dx.doi.org/10.1021/jm970417o>10.1021/jm970417o</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Urien S, Pinquier JL, Paquette B, Chaumet RP, Kiechel JR, Tillement JP. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the blood-brain barrier.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1987;242:349&#8211;353.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Tanaka H, Mizojiri K. Drug-protein binding and blood-brain barrier permeability.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1999;288:912&#8211;918.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Pardridge WM, Sakiyama R, Fierer G. Transport of propanolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1983;71:900&#8211;908.</td><td><a href=http://dx.doi.org/10.1172/JCI110844>10.1172/JCI110844</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Pardridge WM. Recent advances in blood-brain barrier transport.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol</Emphasis>. 1988;28:25&#8211;39.</td><td><a href=http://dx.doi.org/10.1146/annurev.pa.28.040188.000325>10.1146/annurev.pa.28.040188.000325</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibBook</td><td>Davson H, Segal MB. Physiology of the CSF and blood-brain barriers. Boca Raton, FL: CRC Press; 1996.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Vorbrodt AW. Ultrastructural cytochemistry of blood-brain barrier endothelia.<Emphasis Type="Italic">Prog Histochem Cytochem</Emphasis>. 1988;18:1&#8211;99.</td><td><a href=http://dx.doi.org/10.1016/S0079-6336(88)80001-9>10.1016/S0079-6336(88)80001-9</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, VolumeID, ArticleTitle, Year</td><td>CrossRef</td></tr><tr><td>CR50</td><td>BibArticle</td><td>van Bree JB, de Boer AG, Danhof M, Ginsel LA, Breimer DD. Characterization of an &#8220;in vitro&#8221; blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1988;247:1233&#8211;1239.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.<Emphasis Type="Italic">J Drug Target</Emphasis>. 1998;6:151&#8211;165.</td><td><a href=http://dx.doi.org/10.3109/10611869808997889>10.3109/10611869808997889</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Oldendorf WH. Lipid solubility and drug penetration of the blood-brain barrier.<Emphasis Type="Italic">Proc Soc Exp Biol Med</Emphasis>. 1974;147:813&#8211;815.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.3181/00379727-147-38444>10.3181/00379727-147-38444</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Oldendorf WH. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard.<Emphasis Type="Italic">Brain Res.</Emphasis> 1970;24:372&#8211;376.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(70)90123-X>10.1016/0006-8993(70)90123-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1980;23:682&#8211;684.</td><td><a href=http://dx.doi.org/10.1021/jm00180a022>10.1021/jm00180a022</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Rubin LL, Staddon JM. The cell biology of the blood-brain barrier.<Emphasis Type="Italic">Annu Rev Neurosci.</Emphasis> 1999;22:11&#8211;28.</td><td><a href=http://dx.doi.org/10.1146/annurev.neuro.22.1.11>10.1146/annurev.neuro.22.1.11</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Suzuki H, Terasaki T, Sugiyama Y. Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system.<Emphasis Type="Italic">Adv Drug Del Rev.</Emphasis> 1997;25:257&#8211;285.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(97)00503-6>10.1016/S0169-409X(97)00503-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Scism JL, Powers KM, Artru AA, et al. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta(2)-valproic acid in rabbits.<Emphasis Type="Italic">Drug Metab Dispos.</Emphasis> 1997;25:1337&#8211;1346.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Deguchi Y, Nowaza K, Yamada S, Yokoyama Y, Kimura R. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis. Possible involvement of the monocarboxylic acid transport system.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1997;280:551&#8211;560.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Schinkel AH, Wagenaar E, Mol CAAM, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.<Emphasis Type="Italic">J Clin Invest.</Emphasis> 1996;97:2517&#8211;2524.</td><td><a href=http://dx.doi.org/10.1172/JCI118699>10.1172/JCI118699</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Schinkel AH, Smit JJM, van Tellingen O, et al. Disruption of the mouse mdr la P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.<Emphasis Type="Italic">Cell.</Emphasis> 1994;77:491&#8211;502.</td><td><a href=http://dx.doi.org/10.1016/0092-8674(94)90212-7>10.1016/0092-8674(94)90212-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.<Emphasis Type="Italic">Anesthesiology</Emphasis>. 2002;96:913&#8211;920.</td><td><a href=http://dx.doi.org/10.1097/00000542-200204000-00019>10.1097/00000542-200204000-00019</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Uhr M, Steckler T, Yassouridis A, Holsboer F. Penetration of amitriptyline, but not of fluoxitine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdrla P-glycoprotein gene disruption.<Emphasis Type="Italic">Neurospsychopharmacology</Emphasis>. 2000;22:380&#8211;387.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(99)00095-0>10.1016/S0893-133X(99)00095-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Mahar Doan KM, Humphreys JE, Webster LO, et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;303:1029&#8211;1037.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.039255>10.1124/jpet.102.039255</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Kim RB. Drugs as P-glycoprotein substrates, inhibitors, and inducers.<Emphasis Type="Italic">Drug Metab Rev</Emphasis>. 2002;34:47&#8211;54.</td><td><a href=http://dx.doi.org/10.1081/DMR-120001389>10.1081/DMR-120001389</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Gross PM, Sposito NM, Pettersen SE, Fenstermacher JD. Differences in function and structure of the capillary endothelium in gray matter, white matter, and a circumventricular organ of rat brain.<Emphasis Type="Italic">Blood Vessels.</Emphasis> 1986;23:261&#8211;270.</td><td><a href=http://dx.doi.org/10.1159/000158652>10.1159/000158652</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_2, Author_FamilyName_1, Year, JournalTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Collins JM, Dedrick LD. Distributed model for drug delivery to CSF and brain tissue.<Emphasis Type="Italic">J Am Physiol.</Emphasis> 1983;14:R303-R310.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR67</td><td>BibBook</td><td>Davson H, Segal MB. Physiology of the CSF and blood-brain barriers. Boca Raton, FL: CRC Press; 1996.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Yu D-W, Gatley SJ, Wolf AP, et al. Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1992;35:2178&#8211;2183.</td><td><a href=http://dx.doi.org/10.1021/jm00090a005>10.1021/jm00090a005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Fenstermacher JD, Patlak CS, Blasberg RG. Transport of material between brain extracellular fluid, brain cells and blood.<Emphasis Type="Italic">Fed Proc.</Emphasis> 1974;33:2070&#8211;2074.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Walker MC, Tong X, Perry H, Alavijeh MS, Patsalos PN. Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine.<Emphasis Type="Italic">Br J Pharmacol.</Emphasis> 2000;130:242&#8211;248.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0703337>10.1038/sj.bjp.0703337</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Lee G, Dallas S, Hong M, Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.<Emphasis Type="Italic">Pharmacol Rev.</Emphasis> 2001;53:569&#8211;596.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Wong SL, Van Belle K, Sawchuk RJ. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid and cerebrospinal fluid blood-barriers in the rabbit: investigation on the inhibitory effect of probenecid utilizing microdialysis.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;264:899&#8211;909.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Ghersi-Egea JF, Leininger-Muller B, Suleman G, Siest G, Minn A. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1994;62:1089&#8211;1096.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1994.62031089.x>10.1046/j.1471-4159.1994.62031089.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Del Bigio MR. The ependyma: a protective barrier between brain and cerebrospinal fluid.<Emphasis Type="Italic">Glia.</Emphasis> 1995;14:1&#8211;13.</td><td><a href=http://dx.doi.org/10.1002/glia.440140102>10.1002/glia.440140102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR75</td><td>BibChapter</td><td>Cserr HF. Convection of brain interstitial fluid. In: Shapiro K, Marmarou A, Portnoy H, eds.<Emphasis Type="Italic">Hydrocephalus</Emphasis>. New York: Raven Press, 1984:59&#8211;68.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1136/jnnp.47.12.1366>10.1136/jnnp.47.12.1366</a></td><td><b>CrossRef-Web</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Bouw R, Ederoth P, Lundberg J, Ungerstedt U, Nordstrom CH, Hammarlund-Udenaes M. Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis.<Emphasis Type="Italic">Acta Anaesthesiol Scand.</Emphasis> 2001;45:390&#8211;392.</td><td><a href=http://dx.doi.org/10.1034/j.1399-6576.2001.045003390.x>10.1034/j.1399-6576.2001.045003390.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR77</td><td>BibArticle</td><td>Bolwig TG, Hertz MM, Paulson OB, Spotoft H, Rafaelsen OJ. The permeability of the blood-brain barrier during electrically induced seizures in man.<Emphasis Type="Italic">Eur J Clin Invest.</Emphasis> 1977;7:87&#8211;93.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2362.1977.tb01578.x>10.1111/j.1365-2362.1977.tb01578.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR78</td><td>BibChapter</td><td>Brosman CF, Claudio L. Brain microvasculature in multiple sclerosis. In: Pardridge, WM, ed.<Emphasis Type="Italic">Introduction to the Blood-Brain Barrier: Methodology, Biology, and Pathology</Emphasis>. Cambridge, UK: Cambridge University Press; 1998:386&#8211;400.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1017/CBO9780511570216>10.1017/CBO9780511570216</a></td><td><b>CrossRef-Meta</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR79</td><td>BibArticle</td><td>de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood-brain barrier in neuro-inflammatory diseases.<Emphasis Type="Italic">Pharmacol Rev.</Emphasis> 1997;49:143&#8211;156.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR80</td><td>BibChapter</td><td>Povlishock JT. The pathophysiology of blood-brain barrier dysfunction due to traumatic brain injury. In: Pardridge, WM, ed.<Emphasis Type="Italic">Introduction to the Blood-Brain Barrier: Methodology, Biology, and Pathology</Emphasis>. Cambridge, UK: Cambridge University Press; 1998:441&#8211;453.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1017/CBO9780511570216>10.1017/CBO9780511570216</a></td><td><b>CrossRef-Meta</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR81</td><td>BibChapter</td><td>Steward PA, Mikulis D. The blood-brain barrier in brain tumours. In: Pardridge WM, ed.<Emphasis Type="Italic">Introduction to the Blood-Brain Barrier: Methodology, Biology, and Pathology</Emphasis>. Cambridge, UK: Cambridge University Press; 1998:434&#8211;440.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1017/CBO9780511570216>10.1017/CBO9780511570216</a></td><td><b>CrossRef-Meta</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR82</td><td>BibArticle</td><td>de Rick AF, Belpaire FM, Dello C, Bogaert MG. Influence of enhanced AAG concentration on protein binding, pharmacokinetics and anti-arrhythmic effect of lidocaine in the dog.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1987;241:289&#8211;293.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR83</td><td>BibArticle</td><td>Jolliet P, Simon N, Bree F, et al. Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1997;14:650&#8211;656.</td><td><a href=http://dx.doi.org/10.1023/A:1012165414610>10.1023/A:1012165414610</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR84</td><td>BibArticle</td><td>Lin TH, Sawada Y, Sugiyama Y, Iga T, Hanano M. Effects of albumin and alpha 1-acid glycoprotein on the transport of imipramine and desipramine through the blood-brain barrier in rats.<Emphasis Type="Italic">Chem Pharm Bull (Tokyo)</Emphasis>. 1987;35:294&#8211;301.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1248/cpb.35.294>10.1248/cpb.35.294</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID</td><td>CrossRef</td></tr><tr><td>CR85</td><td>BibArticle</td><td>Mandema JW, Sansom LN, Dios-Vi&#232;itez MC, Hollander-Jansen M, Danhof M. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1991;257:472&#8211;478.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR86</td><td>BibArticle</td><td>Mandema JW, Tukker E, Danhof M. Pharmacokinetic-Pharmacodynamic Modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1991;102:663&#8211;668.</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1991.tb12230.x>10.1111/j.1476-5381.1991.tb12230.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_1, Author_FamilyName_2, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR87</td><td>BibArticle</td><td>Derendorf H, Hochhaus G, Mollmann H, et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids.<Emphasis Type="Italic">J Clin Pharmacol</Emphasis>. 1993;33:115&#8211;123.</td><td><a href=http://dx.doi.org/10.1002/j.1552-4604.1993.tb03930.x>10.1002/j.1552-4604.1993.tb03930.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Year, Author_FamilyName_1, Author_FamilyName_2, VolumeID, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR88</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#FFFF80'>van</span> <span style='background:#BCBCBC'>Steeg</span> <span style='background:#DDDDDD'>T</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Macintyre</span> <span style='background:#DDDDDD'>F</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Danhof</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#FFFF80'>de</span> <span style='background:#BCBCBC'>Lange</span> <span style='background:#DDDDDD'>ECM.</span></span>, <span style='background:#BDBAD6'>The influence of an increase in plasma protein binding on the pharmacokinetics and pharmacodynamics of S(&#8211;)-Propranolol. Poster presentation at the Population Approach Group Europe (PAGE),</span></aug> <span style='background:#66FF66'>2005</span>, <span style='background:#C0FFC0'>Pamplona, Spain</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR89</td><td>BibArticle</td><td>Tunblad K, Ederoth P, Gardenfors A, Hammarlund-Udenaes M, Nordstrom CH. Altered brain exposure of morphine in experimental meningitis studied with microdialysis.<Emphasis Type="Italic">Acta Anaesthesiol Scand</Emphasis>. 2004;48:294&#8211;301.</td><td><a href=http://dx.doi.org/10.1111/j.0001-5172.2003.0311.x>10.1111/j.0001-5172.2003.0311.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR90</td><td>BibArticle</td><td>Tunblad K, Jonsson EN, Hammarlund-Udenaes M. Morphine blood-brain barrier transport is influenced by probenecid co-administration.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2003;20:618&#8211;623.</td><td><a href=http://dx.doi.org/10.1023/A:1023250900462>10.1023/A:1023250900462</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR91</td><td>BibArticle</td><td>Bouw MR, Xie R, Tunblad K, Hammarlund-Udenaes M. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats&#8212;pharmacokinetic/pharmacodynamic modelling.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2001;134:1796&#8211;804.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0704406>10.1038/sj.bjp.0704406</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR92</td><td>BibArticle</td><td>Bouw MR, Gardmark M, Hammarlund-Udenaes M. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats&#8212;a microdialysis study.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:1220&#8211;1227.</td><td><a href=http://dx.doi.org/10.1023/A:1026414713509>10.1023/A:1026414713509</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR93</td><td>BibArticle</td><td>Dagenais C, Graff CL, Pollack GM. Variable modulation of opioid brain uptake by P-glycoprotein in mice.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2004;67:269&#8211;276.</td><td><a href=http://dx.doi.org/10.1016/j.bcp.2003.08.027>10.1016/j.bcp.2003.08.027</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR94</td><td>BibArticle</td><td>Henthorn TK, Liu Y, Mahapatro M, Ng KY. Active transport of fentanyl by the blood-brain barrier.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1999;289:1084&#8211;1089.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR95</td><td>BibArticle</td><td>Letrent SP, Pollack GM, Brouwer KR, Brouwer KL. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1998;15:599&#8211;605.</td><td><a href=http://dx.doi.org/10.1023/A:1011938112599>10.1023/A:1011938112599</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR96</td><td>BibArticle</td><td>Letrent SP, Pollack GM, Brouwer KR, Brouwer KL. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1999;27:827&#8211;834.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR97</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Groenendaal</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#FFFF80'>de</span> <span style='background:#BCBCBC'>Mik</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Nicholls</span> <span style='background:#DDDDDD'>G</span></span>, et al.</aug> Towards a mechanism-based pharmacokinetic/pharmacodynamic model for opioids: influence of P-glycoprotein and apparent permeability in vitro. Submitted, <span style='background:#66FF66'>2005</span>. <span style='background:#FFFF0F'>Jake has AQ out on status</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR98</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Groenendaal</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#FFFF80'>de</span> <span style='background:#BCBCBC'>Mik</span> <span style='background:#DDDDDD'>D</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Freijer</span> <span style='background:#DDDDDD'>J</span></span>, et al.</aug> <span style='background:#FFD9B3'>Towards a mechanism-based pharmacokinetic/pharmacodynamic model for opioids: combined microdialysis/EEG studies on morphine. Poster presentation at the 4th International Symposium on Microdialysis in Drug Research and Development</span>, <span style='background:#C0FFC0'>Vienna, Austria</span>, <span style='background:#66FF66'>2004</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR99</td><td>BibArticle</td><td>Sills GJ, Kwan P, Butler E, de Lange EC, van den Berg DJ Brodie MJ. P-glycoprotein-mediated efflux of anti-epileptic drugs: preliminary studies in mdrla knockout mice.<Emphasis Type="Italic">Epilepsy Behav</Emphasis>. 2002;3:427&#8211;432.</td><td><a href=http://dx.doi.org/10.1016/S1525-5050(02)00511-5>10.1016/S1525-5050(02)00511-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR100</td><td>BibArticle</td><td>Kwan P, Brodie MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.<Emphasis Type="Italic">Epilepsia</Emphasis>. 2005;46:224&#8211;235.</td><td><a href=http://dx.doi.org/10.1111/j.0013-9580.2005.31904.x>10.1111/j.0013-9580.2005.31904.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR101</td><td>BibArticle</td><td>Gibbs JP, Adeyeye MC, Yang Z, Shen DD. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.<Emphasis Type="Italic">Epilepsy Res</Emphasis>. 2004;58:53&#8211;66.</td><td><a href=http://dx.doi.org/10.1016/j.eplepsyres.2003.12.008>10.1016/j.eplepsyres.2003.12.008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR102</td><td>BibArticle</td><td>Volk HA, Burkhardt K, Potschka H, Chen J, Becker A, Loscher W. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2004;123:751&#8211;759.</td><td><a href=http://dx.doi.org/10.1016/j.neuroscience.2003.10.012>10.1016/j.neuroscience.2003.10.012</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR103</td><td>BibArticle</td><td>Marroni M, Marchi N, Cucullo L, Abbott NJ, Signorelli K, Janigro D. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.<Emphasis Type="Italic">Curr Drug Targets</Emphasis>. 2003;4:297&#8211;304.</td><td><a href=http://dx.doi.org/10.2174/1389450033491109>10.2174/1389450033491109</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR104</td><td>BibArticle</td><td>Seiffert E, Dreier JP, Ivens S, et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2004;24:7829&#8211;7836.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.1751-04.2004>10.1523/JNEUROSCI.1751-04.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR105</td><td>BibArticle</td><td>Nitsch C, Klatzo I. Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents.<Emphasis Type="Italic">J Neurol Sci</Emphasis>. 1983;59:305&#8211;322.</td><td><a href=http://dx.doi.org/10.1016/0022-510X(83)90016-3>10.1016/0022-510X(83)90016-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR106</td><td>BibArticle</td><td>Petito CK, Schaefer JA, Plum F. Ultrastructural characteristics of the brain and blood-brain barrier in experimental seizures.<Emphasis Type="Italic">Brain Res</Emphasis>. 1977;127:251&#8211;267.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(77)90539-X>10.1016/0006-8993(77)90539-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR107</td><td>BibArticle</td><td>Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy.<Emphasis Type="Italic">Epilepsia</Emphasis>. 1995;36:1&#8211;6.</td><td><a href=http://dx.doi.org/10.1111/j.1528-1157.1995.tb01657.x>10.1111/j.1528-1157.1995.tb01657.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR108</td><td>BibArticle</td><td>Voskuyl RA, Hoogerkamp A, Danhof M. Properties of the convulsive threshold determined by direct cortical stimulation in rats.<Emphasis Type="Italic">Epilepsy Res</Emphasis>. 1992;12:111&#8211;120.</td><td><a href=http://dx.doi.org/10.1016/0920-1211(92)90031-N>10.1016/0920-1211(92)90031-N</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR109</td><td>BibArticle</td><td>Hoogerkamp A, Vis PW, Danhof M, Voskuyl RA. Characterization of the pharmacodynamics of several anti-epileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1994;269:521&#8211;528.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR110</td><td>BibArticle</td><td>Radulovic LL, Turck D, von Hodenberg A, et al. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1995;23:441&#8211;448.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR111</td><td>BibArticle</td><td>Vollmer KO, von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.<Emphasis Type="Italic">Arzneimittelforschung</Emphasis>. 1986;36:830&#8211;839.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR112</td><td>BibArticle</td><td>Doble A. Excitatory amino acid receptors and neurodegeneration.<Emphasis Type="Italic">Therapie</Emphasis>. 1995;50:319&#8211;337.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR113</td><td>BibArticle</td><td>Gerlach M, Desser H, Youdim MB, Riederer P. New horizons in molecular mechanisms underlying Parkinson&#8217;s disease and in our understanding of the neuroprotective effects of selegiline.<Emphasis Type="Italic">J Neural Transm Suppl</Emphasis>. 1996;48:7&#8211;21.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR114</td><td>BibArticle</td><td>Gerlach M, Youdim MB, Riederer P. Pharmacology of selegiline.<Emphasis Type="Italic">Neurology</Emphasis>. 1996;47(suppl 3):S137-S145.</td><td><a href=http://dx.doi.org/10.1212/WNL.47.6_Suppl_3.137S>10.1212/WNL.47.6_Suppl_3.137S</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, ArticleTitle, VolumeID, Year, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR115</td><td>BibArticle</td><td>Mitchell IJ, Carroll CB. Reversal of parkinsonian symptoms in primates by antagonists of excitatory amino acid transmission: potential mechanisms of action.<Emphasis Type="Italic">Neurosci Biobehav Rev</Emphasis>. 1997;21:469&#8211;475.</td><td><a href=http://dx.doi.org/10.1016/S0149-7634(96)00036-X>10.1016/S0149-7634(96)00036-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR116</td><td>BibArticle</td><td>Paschen W. Polyamine metabolism in different pathological states of the brain.<Emphasis Type="Italic">Mol Chem Neuropathol</Emphasis>. 1992;16:241&#8211;271.</td><td><a href=http://dx.doi.org/10.1007/BF03159973>10.1007/BF03159973</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR117</td><td>BibArticle</td><td>Bernstein HG, M&#252;ller M. The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 1999;57:485&#8211;505.</td><td><a href=http://dx.doi.org/10.1016/S0301-0082(98)00065-3>10.1016/S0301-0082(98)00065-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR118</td><td>BibArticle</td><td>Kauppinen RA, Alhonen LI. Transgenic animals as models in the study of the neurobiological role of polyamines.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 1995;47:545&#8211;563.</td><td><a href=http://dx.doi.org/10.1016/0301-0082(95)00037-2>10.1016/0301-0082(95)00037-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR119</td><td>BibArticle</td><td>Williams K. Modulation and block of ion channels: a new biology of polyamines.<Emphasis Type="Italic">Cell Signal</Emphasis>. 1997;9:1&#8211;13.</td><td><a href=http://dx.doi.org/10.1016/S0898-6568(96)00089-7>10.1016/S0898-6568(96)00089-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR120</td><td>BibArticle</td><td>Williams K, Romano C, Dichter MA, Molinoff PB. Modulation of the NMDA receptor by polyamines.<Emphasis Type="Italic">Life Sci</Emphasis>. 1991;48:469&#8211;498.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(91)90463-L>10.1016/0024-3205(91)90463-L</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR121</td><td>BibArticle</td><td>Baskaya MK, Rao AM, Prasad MR, Dempsey RJ. Regional activity of ornithine decarboxylase and edema formation after traumatic brain injury.<Emphasis Type="Italic">Neurosurgery</Emphasis>. 1996;38:140&#8211;145.</td><td><a href=http://dx.doi.org/10.1097/00006123-199601000-00033>10.1097/00006123-199601000-00033</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR122</td><td>BibArticle</td><td>Koenig H, Trout JJ, Goldstone AD, Lu CY. Capillary NMDA receptors regulate blood-brain barrier function and breakdown.<Emphasis Type="Italic">Brain Res</Emphasis>. 1992;588:297&#8211;303.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(92)91589-7>10.1016/0006-8993(92)91589-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR123</td><td>BibArticle</td><td>Poduslo JF, Curran GL. Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1996;66:1599&#8211;1609.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1996.66041599.x>10.1046/j.1471-4159.1996.66041599.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR124</td><td>BibArticle</td><td>Trout JJ, Koenig H, Goldstone AD, Lu CY. Blood-brain barrier breakdown in cold injury. Polyamine signals mediate active stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries.<Emphasis Type="Italic">Lab Invest</Emphasis>. 1986;55:622&#8211;631.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR125</td><td>BibArticle</td><td>Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson&#8217;s disease.<Emphasis Type="Italic">Nat Neurosci</Emphasis>. 2000;3:1301&#8211;1306.</td><td><a href=http://dx.doi.org/10.1038/81834>10.1038/81834</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR126</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ravenstijn</span> <span style='background:#DDDDDD'>P</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Merlini</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hameetman</span> <span style='background:#DDDDDD'>M</span></span>, et al.</aug> <span style='background:#FFD9B3'>Blood-brain barrier permeability in Parkinson&#8217;s disease progression using the rotenone rat model. Poster presentation at the 4th International Symposium on Microdialysis in Drug Research and Development</span>, <span style='background:#C0FFC0'>Vienna, Austria</span>, <span style='background:#66FF66'>2004</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>